Indeed, genetic inhibition of both YAP1 and STAT3 decreased the stem cell-like features of lung adenocarcinoma cells, resulting in reduced proliferation and enhanced cisplatin sensitivity. The gene discussed is YAP1; the disease is lung adenocarcinoma.